Genentech, Inc. v. Chiron Corp. — Reduction to Practice Requires Inventors to Recognize Utility, Not Just a Third Party
The Federal Circuit reversed a finding of priority in favor of Genentech, holding that reduction to practice of a recombinant protein invention requires the inventors themselves — not a third party — to recognize the utility of what they have made.